エピソード

  • Highlights From AECOS Europe 2025

    Highlights From AECOS Europe 2025
    2025/07/17
    This special edition of CRST: The Podcast, recorded live at AECOS Europe 2025 in London, features six discussions from Eyetube’s Meeting Coverage. Topics include patient selection and long-term outcomes in presbyopia correction, advances in keratorefractive lenticule extraction, innovation in IOL customization, automated slit lamp imaging integration, solid-state laser technology, adjustable lens use in complex cases, and keratopigmentation techniques.
    続きを読む 一部表示
    39 分
  • Refractive Innovation in Private Practice

    Refractive Innovation in Private Practice
    2025/07/09
    Neda Shamie, MD, sits down with George O. Waring IV, MD, FACS, for a conversation about his journey from academic medicine to founding the Waring Vision Institute in Charleston, South Carolina. They explore his philosophy toward refractive care, the origin and impact of the term dysfunctional lens syndrome, and how his practice uniquely blends research, surgical innovation, and patient-centered care.
    続きを読む 一部表示
    31 分
  • Exploring the Launch of LACRIFILL® Canalicular Gel

    Exploring the Launch of LACRIFILL® Canalicular Gel
    2025/07/01
    Jai Parekh, MD, MBA, FAAO, chief commercial officer for Nordic Pharma Inc., and Phil Gioia, president of Nordic Pharma Inc., invite Darrell White, MD, to share his real-world experiences with LACRIFILL® Canalicular Gel.
    続きを読む 一部表示
    16 分
  • One-Year Clinical and Real-World Outcomes with the TENEO Excimer

    One-Year Clinical and Real-World Outcomes with the TENEO Excimer
    2025/06/20
    In this episode, Drs. Waring and Chu share clinical insights and real-world experience from the first year of using the Teneo 317 excimer laser for correcting myopia and myopic astigmatism. As the first excimer platform to receive FDA approval in over 15 years, the Teneo 317 introduces modern performance to U.S. practices with its compact design, fast ablation speed, and intuitive user interface. The conversation covers key findings from the FDA clinical trial and early post-market use, including exceptional visual acuity outcomes, improved night vision, and high levels of patient satisfaction. Sponsored by Bausch + Lomb©2025 Bausch + Lomb TEN.0014.USA.25
    続きを読む 一部表示
    38 分
  • Empowering Cataract Patients

    Empowering Cataract Patients
    2025/06/17
    Drs. Neda and Neda sit down with John A. Hovanesian, MD, to unpack how to truly empower cataract patients in today’s practice. They share practical insights on building trust, handling patient fears, and guiding decision-making for premium IOLs and lifestyle vision goals.
    続きを読む 一部表示
    32 分
  • The Six Stages of Practice Growth

    The Six Stages of Practice Growth
    2025/06/11
    Laura Livesey and Rod Solar unpack the six stages of private ophthalmology practice growth—from launching and gaining visibility to optimizing operations at scale. They explore the key challenges at each stage and the strategies practices can use to progress, offering a clear, practical framework to identify your current stage and plan your next steps.
    続きを読む 一部表示
    35 分
  • State of Play in Office-Based Surgery

    State of Play in Office-Based Surgery
    2025/06/02
    What does the landscape look like for office-based surgery? And what are on-the-ground experiences telling us about the future of eye care? Join moderator John A. Hovanesian, MD, as he hears from Mark Lobanoff, MD, andDagny Zhu, MD, both of whom have extensive experience with office-based surgery. Hear about their insights, their unexpected (pleasant) surprises, and their specific approaches in this special coverage on CRST: The Podcast.
    続きを読む 一部表示
    27 分
  • From Insight to Innovation

    From Insight to Innovation
    2025/05/21
    Eric D. Rosenberg, DO, MScEng, and Vance Thompson, MD, discuss how everyday surgical observations can lead to impactful innovations. Together, they explore the evolution of femtosecond laser techniques, the role of AI in ophthalmology, and the value of sharing incremental insights.
    続きを読む 一部表示
    46 分